ICD-10-CM/PCS MS-DRG v43.0 Definitions Manual |
||||
| Skip to content |
| Pre-MDC |
| Autologous Bone Marrow Transplant |
| Bone Marrow Transplant | CC or MCC | DRG |
|---|---|---|
| Yes | Yes | 016 |
| Yes | No | 017 |
DRG 016 Autologous Bone Marrow Transplant with CC/MCC
DRG 017 Autologous Bone Marrow Transplant without CC/MCC
BONE MARROW TRANSPLANT
NON-OPERATING ROOM PROCEDURES
| 30233AZ* | Transfusion of Embryonic Stem Cells into Peripheral Vein, Percutaneous Approach |
| 30233C0* | Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Peripheral Vein, Percutaneous Approach |
| 30233G0* | Transfusion of Autologous Bone Marrow into Peripheral Vein, Percutaneous Approach |
| 30233X0* | Transfusion of Autologous Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach |
| 30233Y0* | Transfusion of Autologous Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach |
| 30243AZ* | Transfusion of Embryonic Stem Cells into Central Vein, Percutaneous Approach |
| 30243C0* | Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Central Vein, Percutaneous Approach |
| 30243G0* | Transfusion of Autologous Bone Marrow into Central Vein, Percutaneous Approach |
| 30243X0* | Transfusion of Autologous Cord Blood Stem Cells into Central Vein, Percutaneous Approach |
| 30243Y0* | Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach |
| XW1337A* | Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10 |
| XW133B8* | Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8 |
| XW133F8* | Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8 |
| XW133G8* | Transfusion of Atidarsagene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8 |
| XW133H9* | Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9 |
| XW133J8* | Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8 |
| XW133SB* | Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11 |
| XW1437A* | Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10 |
| XW143B8* | Transfusion of Betibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8 |
| XW143F8* | Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8 |
| XW143G8* | Transfusion of Atidarsagene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8 |
| XW143H9* | Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9 |
| XW143J8* | Transfusion of Exagamglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8 |
| XW143SB* | Transfusion of Mozafancogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 11 |
|
Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244 22 Jul 2025 11:22:30 CMS, code-revision=376, description-revision=1445 |